US Blood Collection Devices Market (2025-2030)
The US Blood Collection Devices Market was valued at $768.2 Million in 2025 and projected to reach to $1070.7 Million by 2030, representing a compound annual growth rate of 6.9%. The US blood collection devices market is poised for steady growth driven by increasing healthcare spending, rising diagnostic testing demand, and regulatory emphasis on occupational safety.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
US Blood Collection Devices Market Trends and Insights
- The US market benefits from advanced healthcare infrastructure, high diagnostic testing volumes, and increasing demand for safer phlebotomy solutions.
- In the US, rising prevalence of chronic diseases and aging demographics are driving sustained demand for blood collection across hospitals, diagnostic laboratories, and blood banks. The US blood collection devices market is characterized by strong adoption of safety-engineered devices and automation technologies.
- Throughout the 2025–2030 forecast period, the US is expected to maintain steady growth driven by regulatory compliance requirements and healthcare provider investments in infection prevention.
- The US market reflects robust competition among established manufacturers and emerging innovators focused on improving collection efficiency and patient safety..
Key Market Statistics
- CAGR (2025-2030) 6.9% CAGR
- Market Size, 2025 ~USD 768.2 Million
- Forecast, 2030 ~USD 1070.7 Million
- Country US
US Blood Collection Devices Market Overview
Market Size & Growth :
The US blood collection devices market is valued at $768.2 million in 2025 and is projected to reach $1,070.7 million by 2030, representing a CAGR of 6.9% over the forecast period.
Advanced Healthcare Infrastructure :
The US benefits from a mature healthcare system with high diagnostic testing volumes, extensive laboratory networks, and significant investment in phlebotomy safety standards and automation technologies.
Safety-Driven Demand :
Increasing adoption of safer needle devices, needlestick injury prevention regulations, and healthcare worker protection initiatives are driving demand for innovative blood collection solutions across US medical facilities.
Aging Population & Chronic Disease :
Rising prevalence of chronic diseases such as diabetes, cardiovascular conditions, and cancer, combined with an aging demographic, is fueling higher diagnostic testing volumes and blood collection device utilization in the US.
US Blood Collection Devices Market Dynamics
- Healthcare providers are increasingly investing in advanced phlebotomy solutions, including safety-engineered devices and integrated collection systems, to reduce needlestick injuries and improve operational efficiency.
- The aging US population and growing prevalence of chronic diseases will continue to drive demand for blood testing and collection services across hospitals, diagnostic laboratories, and outpatient care centers.
- Additionally, technological innovations in device design and automation are expected to enhance market penetration and support sustained expansion through 2030..
Related Ecosystem
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- The US blood collection devices market is valued at $768.2 million in 2025 and will reach $1,070.7 million by 2030, representing a 6.9% CAGR.
- The US market is driven by aging demographics, chronic disease prevalence, and strong healthcare infrastructure supporting high diagnostic testing volumes.
- Safety-engineered devices and automation technologies are key growth drivers in the US market through 2030.
- The US regulatory environment and infection prevention mandates continue to fuel healthcare provider investments in advanced blood collection solutions.
Blood Collection Devices Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | PLASMA/WHOLE BLOOD TUBES (Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 7.4% from 2025 to 2030 |
| Largest Segment | MANUAL BLOOD COLLECTION (Method) |
| Market Size Base Year (Billions) | ~USD 9.11 (2025) |
| Revenue Forecast (Billions) | ~USD 13.02 (2030) |
| Segments Covered | Product, Type, System Type, Method, Application, End User |
US Blood Collection Devices Market Report Segmentation
6 segment dimensions are covered across the global market.
By Product
- Blood Bags
- Blood Collection Systems/ Monitors
- Blood Collection Tubes
- Lancets
- Needle & Syringes
By Type
- Coagulation Tubes
- Edta Tubes
- Esr Tubes
- Glucose Tubes
- Heparin Tubes
- Plasma/Whole Blood Tubes
- Serum Tubes
By System Type
- Non-Vacuum Type
- Vacuum Type
By Method
- Automated Blood Collection
- Manual Blood Collection
By Application
- Diagnostic Applications
- Therapeutic Applications
By End User
- Blood Banks
- Diagnostic & Pathology Labs
- Hospitals, Ambulatory Surgical Centers, And Nursing Homes
- Other End Users
US: BLOOD COLLECTION DEVICES MARKET, BY END USER, 2023–2030
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| BLOOD BANKS | 394.4 | 413.1 | 428.7 | 446.2 | 466.7 | 489.6 | 515.1 | 543.6 | 4.9 |
| DIAGNOSTIC & PATHOLOGY LABS | 531.5 | 564.7 | 594.2 | 627.3 | 665.4 | 708 | 755.6 | 808.7 | 6.4 |
| HOSPITALS, AMBULATORY SURGICAL CENTERS, AND NURSING HOMES | 1270 | 1360.5 | 1443.5 | 1536 | 1642.3 | 1760.9 | 1893.4 | 2041.5 | 7.2 |
| OTHER END USERS | 144.6 | 150.7 | 155.6 | 161.2 | 167.7 | 175 | 183.3 | 192.4 | 4.3 |
| TOTAL | 2340.5 | 2489 | 2622 | 2770.6 | 2942.1 | 3133.5 | 3347.4 | 3586.3 | 6.5 |
Target Audience
- Medical Device Manufacturers : US-based and international device manufacturers need detailed market intelligence to develop competitive products, identify distribution channels, and establish market entry strategies in the lucrative American blood collection market.
- Healthcare Facility Administrators : Hospital and laboratory administrators require market insights to optimize procurement decisions, evaluate device suppliers, and implement cost-effective phlebotomy solutions that meet safety and efficiency standards.
- Diagnostic Laboratory Operators : Clinical laboratory managers need market data to assess equipment investments, understand technology trends, and select blood collection systems that enhance operational efficiency and patient safety outcomes.
- Healthcare Investors & Consultants : Investment firms and management consultants require comprehensive US market analysis to evaluate investment opportunities, assess portfolio companies, and provide strategic guidance to healthcare sector clients.
- Regulatory & Compliance Officers : Healthcare compliance professionals need US-specific market and regulatory insights to ensure organizational adherence to safety standards, occupational health regulations, and quality benchmarks in blood collection practices.
Key Companies in the US Blood Collection Devices Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| ATS AUTOMATION TOOLING SYSTEMS INC | Canada | Public Company | Turnkey automation systems (design, build, commissioning),Pre- and post-automation services,Software and digital solutions, |
| ABBOTT LABORATORIES | United States | Public Company | Medical Devices (cardiovascular, diabetes care, neuromodulation),Diagnostic Products (lab, rapid, molecular, point-of-care),Nutritional Products (pediatric, adult, infant formula), |
| NOLATO | Sweden | Public Company | Medical technology components and systems,Pharmaceutical and primary plastic packaging,EMC shielding and thermal management (Compatherm, Compashield, Trishield, MIL SPEC), |
| QIAGEN NV | Netherlands | Public Company | Sample technology consumables and instruments,Immune response (TB IGRA and transplant/viral load assays),Oncology and sexual & reproductive health assays, |
| DANAHER CORPORATION | United States | Public Company | Biotechnology (bioprocessing and related solutions),Life Sciences (research tools and genomic medicine inputs),Diagnostics (clinical instruments and consumables), |
| GRIFOLS, S.A. | Spain | Public Company | Biopharma (plasma-derived medicines),Diagnostic,Bio Supplies, |
| NIPRO CORPORATION | Japan | Public Company | Renal care (hemodialysis machines, dialyzers, blood tubing sets),Injection and infusion devices (syringes, catheters, IV sets),Pharmaceutical packaging (glass vials, ampoules, components), |
| HAEMONETICS CORPORATION | United States | Public Company | Plasma (NexSys PCS, NexLynk DMS, Donor360 and related disposables),Blood Center (whole blood and component collection, software),Hospital Hemostasis & Autotransfusion (TEG 6s, TEG Manager, Cell Saver Elite+), |
| ICU MEDICAL, INC. | United States | Public Company | Infusion therapy & IV solutions,Vascular access & needlefree connectors,Infusion pumps & hardware, |
| CARDINAL HEALTH | United States | Public Company | Branded and Generic Pharmaceutical Distribution,Specialty Pharmaceutical and Manufacturer Services,Medical, Surgical, and Laboratory Products (Cardinal-branded and National Brands), |
| RETRACTABLE TECHNOLOGIES, INC. | United States | Public Company | VanishPoint safety syringes (insulin, tuberculin, allergy antigen),Blood collection sets and tube holders,IV safety catheters and Patient Safe syringes/Luer Caps, |
| AB MEDICAL CO., LTD. | Ireland | Public Company | Cardiovascular Portfolio,Medical Surgical Portfolio,Neuroscience Portfolio, |
ATS AUTOMATION TOOLING SYSTEMS INC
ATS Automation Tooling Systems Inc is a Canadian public company founded in 1978 with 7,000 employees. The company specializes in automation and tooling systems for industrial applications.
ABBOTT LABORATORIES
Abbott Laboratories is a major American public pharmaceutical and healthcare company founded in 1888 with 115,000 employees. The company manufactures and distributes pharmaceuticals, diagnostics, and medical devices globally.
NOLATO
Nolato is a Swedish public company founded in 1938 with 5,607 employees. The company manufactures plastic components and solutions for medical, healthcare, and industrial applications.
QIAGEN NV
QIAGEN NV is a Dutch public company founded in 1984 with 5,500 employees. The company develops and manufactures molecular diagnostics, life sciences, and sample preparation technologies.
DANAHER CORPORATION
Danaher Corporation is a major American public conglomerate founded in 1969 with 59,000 employees. The company operates across multiple sectors including diagnostics, life sciences, and environmental solutions.
GRIFOLS, S.A.
Grifols, S.A. is a Spanish public company founded in 1909 with 25,000 employees. The company develops, manufactures, and distributes plasma-derived medicines and diagnostic solutions.
NIPRO CORPORATION
Nipro Corporation is a Japanese public company founded in 1954. The company manufactures medical devices, pharmaceuticals, and healthcare products.
HAEMONETICS CORPORATION
Haemonetics Corporation is an American public company founded in 1971 with 3,009 employees. The company develops and manufactures blood management and diagnostic solutions.
ICU MEDICAL, INC.
ICU Medical, Inc is an American public company founded in 1984 with 13,000 employees. The company manufactures infusion therapy and critical care medical devices.
CARDINAL HEALTH
Cardinal Health is an American public company founded in 1979 with 55,392 employees. The company is a leading distributor of pharmaceuticals, medical supplies, and healthcare services.
RETRACTABLE TECHNOLOGIES, INC.
Retractable Technologies, Inc is an American public company founded in 1994 with 198 employees. The company manufactures safety-engineered medical devices, including retractable syringes and needles.
AB MEDICAL CO., LTD.
AB Medical Co., Ltd is an Irish public company founded in 1949 with 95,000 employees. The company develops and manufactures medical devices and healthcare solutions.
Reasons to Buy this Report
- US-Specific Market Sizing : Obtain precise market valuation and forecasts tailored exclusively to the US market, enabling accurate budgeting and investment decisions for US-based healthcare organizations and device manufacturers.
- Regulatory & Compliance Insights : Understand US-specific regulatory requirements, OSHA standards, and safety mandates driving blood collection device adoption, ensuring your products and strategies align with American healthcare compliance frameworks.
- Competitive Landscape Analysis : Identify leading US market players, competitive positioning, and market share distribution to benchmark your organization against key competitors and identify growth opportunities in the American market.
- Demographic & Clinical Trends : Leverage insights on US aging demographics, chronic disease prevalence, and diagnostic testing patterns to develop targeted marketing strategies and product development roadmaps for American healthcare providers.
- Strategic Growth Planning : Use comprehensive US market data to inform expansion strategies, partnership opportunities, and investment decisions for maximizing market penetration and revenue growth in the world's largest healthcare market.
Frequently asked questions
What is the current size of the US blood collection devices market?
The US blood collection devices market is estimated at $768.2 million in 2025.
What is the projected size of the US blood collection devices market by 2030?
The US blood collection devices market is forecast to reach $1,070.7 million by 2030.
What is the growth rate of the US blood collection devices market?
The US blood collection devices market is expected to grow at a compound annual growth rate of 6.9% from 2025 to 2030.
What factors are driving growth in the US blood collection devices market?
Key drivers in the US include aging demographics, rising chronic disease prevalence, advanced healthcare infrastructure, regulatory compliance requirements, and increased adoption of safety-engineered devices.
Which segments are most important in the US blood collection devices market?
The US market encompasses hospitals, diagnostic laboratories, blood banks, and other healthcare facilities utilizing safety-engineered collection devices and automation technologies.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global blood collection devices market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects in the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global blood collection devices market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects in the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the blood collection devices market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Blood collection is the process of acquiring blood samples from patients for diagnostic and therapeutic purposes. It is an integral part of the diagnosis and blood group typing process in hospitals and blood bank centers. The blood collection devices market covers the products used to collect blood from patients/donors.
Stakeholders
- Healthcare Service Providers (Hospitals and Pathology Centers)
- Blood Collection Product Manufacturers
- Blood Banks
- Non-governmental Organizations (NGOs) and Government Organizations Associated with Blood Collection
- Market Research and Consulting Firms
- Venture Capitalists and Investors
Report Objectives
- To define, describe, and segment the global blood collection devices market by product, method, application, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the global blood collection devices market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market players
- To forecast the size of market segments with respect to five major regional segments: North America, Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa
- To profile the key players in the market and comprehensively analyze their market positions and core competencies
- To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, collaborations, and partnerships in the blood collection devices market
Get the Full Blood Collection Devices Market Report
Full forecast, segment splits, and company analysis for all Blood Collection Devices Market.
- China Blood Collection Devices Market
- India Blood Collection Devices Market
- Australia Blood Collection Devices Market
- Rest Of Europe Blood Collection Devices Market
- Rest Of Asia Pacific Blood Collection Devices Market
- Canada Blood Collection Devices Market
- Germany Blood Collection Devices Market
- France Blood Collection Devices Market
- UK Blood Collection Devices Market
- Italy Blood Collection Devices Market
- Spain Blood Collection Devices Market
- Japan Blood Collection Devices Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
